Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients.
There is increasing evidence of a biochemical link between oxidative stress and bone metabolism. Oxidative stress has been shown to be involved in bone resorption as it causes loss of bone mineral density (BMD). Paraoxonase 1 (PON1), can prevent these effects of the oxidative stress on bone formation. It has been suggested that the PON1 gene as possibly implicated in reduced BMD in bone fragility cases. It has been hypothesized that PON1 gene polymorphisms may influence both the risk of osteoporosis and osteopenia occurrence and prognosis. The aim of our study is to evaluate the relationship between PON1 polymorphisms and bone fragility development. Seventy-four osteoporotic, 121 osteopenic and 79 nonosteoporotic postmenopausal women were recruited. For detection of the polymorphisms, polymerase chain reaction-restriction fragment length polymorphism techniques have been used. BMD was measured at the lumbar spine and hip by dual-energy X-ray absorptiometry. Distributions of PON1 (PON 192 and PON 55) polymorphisms in study groups were not significantly different. But, there was medium strength connection between in the osteopenic with control groups regarding PON1 55-PON1 192 haplotypes and we found a power strength connection between in the osteoporosis with control groups regarding PON1 55-PON1 192 haplotypes. Furthermore, subjects with PON1 192RR and PON1 55LL genotypes had lower PON activity values of osteoporotic subject compared to healthy control and this difference was statistically significant (p < 0.05). This result suggest that PON1 genotypes could be higher risk for osteoporosis, as determined by reduced BMD.
Department of Molecular Medicine, The Institute of Experimental Medicine (DETAE), İstanbul University, Capa, 34390, Istanbul, Turkey.
Bahar
B
Toptaş
Özlem
Ö
Kurt
Hülya Yılmaz
HY
Aydoğan
Ilhan
I
Yaylim
Ümit
Ü
Zeybek
Ayse
A
Can
Bedia
B
Agachan
Mehmet
M
Uyar
M Kerem
MK
Özyavuz
Turgay
T
Isbir
D000368:Aged; D000483:Alleles; D043303:Aryldialkylphosphatase / Q000097:blood* / Q000235:genetics*; D015519:Bone Density / Q000235:genetics; D001851:Bone Diseases, Metabolic / Q000097:blood* / Q000235:genetics*; D016022:Case-Control Studies; D004789:Enzyme Activation; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000097:blood / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D014421:Turkey
D043303:Aryldialkylphosphatase; C468406:PON1 protein, human